← All patents

US9144605B2

Recombinant rift valley fever virus encoding a dominant-negative inhibitor of …

University of Texas System

Abstract

Certain embodiments of the invention are directed to methods and compositions comprising a Rift Valley fever virus (RVFV) wherein a heterologous nucleic acid encoding a dsRNA-dependent protein kinase (PKR) inhibitor is inserted into the NSs region of the virus.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Tetsuro Ikegami
Priority date
February 14, 2012
Filing date
February 14, 2013
Grant date
September 29, 2015
Publication date
September 29, 2015
Language
en
Metadata fetched
August 29, 2026 00:23